Brazil establishes criteria for the import of products for in vitro diagnosis of Coronavirus during the Public Health Emergency of International Concern due to the new Coronavirus (Covid-19)

Brazilian Health Regulatory Agency (ANVISA) issued resolution which establishes criteria for the import of products for in vitro diagnosis of Coronavirus during the Public Health Emergency of International Concern due to the new Coronavirus (Covid-19)

Products covered : In vitro diagnosis products

HS Code(s): 3002300, 3822

Proposed date of adoption:In the date of its publication.

Proposed date of entry into force:In the date of its publication.

Final date for comments: Not applied.

If the Proposal/Notification/Regulation will affect your International Business please send us your representation with facts and figures , so that these can be taken up suitably.